Halland et al.
2-Nitr o-5-oxo-3-p h en ylh exa n oic Acid Eth yl Ester (3f)
was purified as a 1:1 diastereomeric mixture by FC using Et2O/
pentane and isolated as a colorless oil. Enantiomeric excess
was determined as for compound 3b after decarboxylation
(EtOH/H2O, Et3N, 50 °C overnight): 1H NMR (CDCl3, mixture
of diastereomers) δ 1.06 (t, J ) 6.8 Hz, 3H), 1.29 (t, J ) 7.6
Hz, 3H), 2.06 (s, 3H), 2.03 (s, 3H), 2.92-3.14 (m, 4H, CH2 for
both diastereomers), 4.05 (q, J ) 7.2 Hz, 1H), 4.07 (q, J ) 6.8
Hz, 1H), 4.22-4.30 (m, 4H, CH2 for both diastereomers), 5.40
(d, J ) 8.8 Hz, 1H), 5.47 (d, J ) 9.6 Hz, 1H), 7.23-7.31 (m,
10H); 13C NMR (CDCl3, mixture of diastereomers) δ 13.4, 13.6,
30.0, 30.1, 41.1, 41.4, 45.0, 45.2, 62.7, 63.1, 91.1, 127.8, 127.9,
128.2, 128.7, 128.8, 136.7, 137.7, 163.1, 163.4, 204.7; HRMS
m/z 302.1004 (M + Na+), calcd for C14H17O5NNa+ 302.1004.
single recrystalization in hexane/2-propanol increased the
enantioselectivity to 98% ee: [RrtD] ) -56.4° (c ) 1.0 g/100
1
mL, EtOH, 98% ee); H NMR (CDCl3) δ 1.50 (s, 3H), 1.55 (s,
3H), 2.06 (s, 3H), 2.85 (dd, J ) 3.2, 17.6 Hz, 1H), 3.11 (dd, J
) 10.4, 17.6 Hz, 1H), 4.01 (dd, J ) 3.2, 10.4 Hz, 1H), 7.36 (d,
J ) 8.8 Hz, 2 H), 8.14 (d, J ) 8.8 Hz, 2 H); 13C NMR (CDCl3)
δ 23.1, 25.1, 30.2, 43.7, 48.2, 90.3, 123.5, 130.0, 145.5, 147.3,
204.2; HRMS m/z 303.0952 (M + Na+), calcd for C13H16O5N2-
Na+ 303.0957.
4-(4-Hyd r oxyp h en yl)-5-m eth yl-5-n itr oh exa n -2-on e (3l)
was purified by FC using Et2O/CH2Cl2 and isolated as a
colorless solid. Enantiomers were separated by HPLC using a
Chiralpak AD chiral stationary phase in hexane/2-propanol
90/10: 1H NMR (CDCl3) δ 1.47 (s, 3H), 1.53 (s, 3H), 2.04 (s,
3H), 2.67 (dd, J ) 3.2, 16.4 Hz, 1H), 3.04 (dd, J ) 10.8, 16.4
Hz, 1H), 3.84 (dd, J ) 3.2, 10.8 Hz, 1H), 5.57 (br s, 1H), 6.68
(d, J ) 8.4 Hz, 2 H), 7.02 (d, J ) 8.4 Hz, 2 H); 13C NMR (CDCl3
+ CD3OD) δ 22.0, 25.3, 30.0, 43.9, 48.1, 91.3, 115.1, 127.9,
130.0, 156.3, 206.7; HRMS m/z 254.1053 (M + Na+), calcd for
5-Nitr o-4,5-d ip h en ylp en ta n -2-on e (3g) was purified by
FC using Et2O/pentane, and the diastereomers were isolated
as colorless solids. Enantiomers were separated by HPLC
using a Chiralcel OB stationary phase in ethanol/hexane 50/
50 for the major diastereomer and a Chiralpak AS chiral
stationary phase in hexane/2-propanol 50/50 for the minor
diastereomer: 1H NMR (CDCl3, minor diastereomer) δ 1.71
(s, 3H), 2.28 (dd, J ) 3.6, 17.2 Hz, 1H), 2.61 (dd, J ) 10.0,
17.2 Hz, 1H), 4.25 (dt, J ) 3.6, 12.4 Hz, 1H), 5.69 (d, J ) 12.0
Hz, 1H), 7.11-7.28 (m, 5H), 7.32-7.35 (m, 3H), 7.50-7.53 (m,
2H); 13C NMR (CDCl3, minor diastereomer) δ 30.6, 44.6, 45.7,
95.5, 127.8, 128.2, 128.3, 128.4, 128.7, 128.9, 132.6, 138.6,
205.1; 1H NMR (CDCl3, major diastereomer) δ 2.01 (s, 3H),
2.78 (dd, J ) 3.2, 17.2 Hz, 1H), 3.11 (dd, J ) 10.4, 17.2 Hz,
1H), 4.32 (dt, J ) 3.2, 11.2 Hz, 1H), 5.69 (d, J ) 11.2 Hz, 1H),
C
13H17O4NNa+ 254.1055.
5-Meth yl-5-n itr o-4-th iop h en -2-ylh exa n -2-on e (3m ) was
purified by FC using Et2O/pentane and isolated as a colorless
oil. Enantiomers were separated by GC using a Chirasil Dex-
CB chiral stationary phase after reductive amination to 2,2,5-
trimethyl-3-(tetrahydrothiophen-2-yl)pyrrolidine 5c and TFA
protection of the amine (TFAA, CH2Cl2, 60 °C, 30 min): 1H
NMR δ 1.53 (s, 3H), 1.62 (s, 3H), 2.06 (s, 3H), 2.65 (dd, J )
3.2, 16.4 Hz, 1H), 3.01 (dd, J ) 10.8, 16.8 Hz, 1H), 4.30 (dd, J
) 3.2, 10.8 Hz, 1H), 6.90-6.95 (m, 2H), 7.20 (dd, J ) 1.2, 5.2
Hz, 1H); 13C NMR δ 22.4, 25.5, 30.3, 44.2, 45.5, 90.9, 124.8,
126.8, 127.4, 140.1, 204.4.
7.04-7.14 (m, 5H), 7.20-7.24 (m, 3H), 7.31-7.34 (m, 2H); 13
C
NMR (CDCl3, major diastereomer) δ 30.6, 44.5, 46.5, 95.1,
127.4, 128.2, 128.3, 128.6, 128.7, 129.6, 132.5, 137.4, 205.0;
HRMS m/z 306.1111 (M + Na+), calcd for C17H17O3NNa+
306.1106.
4-F u r a n -2-yl-5-m eth yl-5-n itr oh exa n -2-on e (3n ) was pu-
rified by FC using Et2O/pentane and isolated as a colorless
oil. Enantiomers were separated by GC using an Chiraldex
G-TA chiral stationary phase: 1H NMR δ 1.49 (s, 3H), 1.56 (s,
3H), 2.07 (s, 3H), 2.52 (dd, J ) 3.2, 17.2 Hz, 1H), 3.07 (dd, J
) 10.8, 17.2 Hz, 1H), 4.10 (dd, J ) 3.2, 10.8 Hz, 1H), 6.17 (d,
J ) 3.6 Hz, 1H), 6.29 (dd, J ) 1.6, 3.2 Hz, 1H), 7.31 (m, 1H);
13C NMR δ 22.3, 25.7, 30.0, 42.0, 42.4, 90.4, 109.1, 110.4, 142.1,
151.1, 204.6; HRMS m/z 248.0898 (M + Na+), calcd for
6-Meth yl-6-n itr o-5-p h en ylh ep ta n -3-on e (3h ) was puri-
fied by FC using Et2O/pentane and isolated as a colorless oil.
Enantiomers were separated by GC using a Chirasil Dex-CB
chiral stationary phase: 1H NMR (CDCl3) δ 0.90 (t, J ) 7.2
Hz, 3H), 1.48 (s, 3H), 1.55 (s, 3H), 2.22 (dq, J ) 18.0, 7.6 Hz,
1H), 2.37 (dq, J ) 18.0, 7.6 Hz, 1H), 2.67 (dd, J ) 3.6, 16.8
Hz, 1H), 3.07 (dd, J ) 10.8, 16.8 Hz, 1H), 3.94 (dd, J ) 3.6,
10.8 Hz, 1H), 7.16-7.19 (m, 2H), 7.23-7.31 (m, 3H); 13C NMR
(CDCl3) δ 7.5, 22.4, 25.9, 36.4, 42.8, 48.8, 91.0, 127.8, 128.5,
129.1, 137.7, 207.8; HRMS m/z 272.1263 (M + Na+), calcd for
C
11H15O4NNa+ 248.0899.
5-Meth yl-5-n itr o-4-p yr id in -2-ylh exa n -2-on e (3o) was
purified by FC using Et2O/pentane and isolated as a colorless
oil. Enantiomers were separated by HPLC using a Chiralcel
OJ chiral stationary phase in hexane/2-propanol 92/8; 1H NMR
(CDCl3) δ 1.43 (s, 3H), 1.62 (s, 3H), 2.03 (s, 3H), 2.56 (dd, J )
2.8, 17.6 Hz, 1H), 3.58 (dd, J ) 10.8, 17.6 Hz, 1H), 4.07 (dd, J
) 2.8, 10.8 Hz, 1H), 7.14 (dd, J ) 5.2, 8.0 Hz, 1H), 7.25 (d, J
) 7.2 Hz, 1H), 7.59 (dt, J ) 1.6, 8.0 Hz, 1H), 8.48 (d, J ) 5.2
Hz, 1H); 13C NMR (CDCl3) δ 22.5, 25.2, 30.2, 43.0, 49.3, 91.1,
122.5, 126.2, 136.3, 148.9, 157.5, 205.8; HRMS m/z 237.1241
(M + Na+), calcd for C12H17O3N2Na+ 237.1239.
4-(1-Meth yl-1-n itr oeth yl)octa n -2-on e (3p ) was purified
by FC using Et2O/pentane and isolated as a colorless oil.
Enantiomers were separated by GC using a Chirasil Dex-CB
chiral stationary phase: 1H NMR (CDCl3) δ 0.86 (t, J ) 6.8
Hz, 3H), 1.03-1.44 (m, 6H), 1.51 (s, 3H), 1.52 (s, 3H), 2.17 (s,
3H), 2.34 (dd, J ) 6.0, 18.4 Hz, 1H), 2.52 (dd, J ) 4.4, 18.4
Hz, 1H), 2.75 (m, 1H); 13C NMR (CDCl3) δ 13.6, 22.5, 23.4,
23.5, 29.7, 30.7, 41.0, 44.7, 91.5, 205.9; HRMS m/z 238.1420
(M + Na+), calcd for C11H21O3NNa+ 238.1419.
4-Isop r op yl-5-m eth yl-5-n itr oh exa n -2-on e (3q) was puri-
fied by FC using Et2O/pentane and isolated as a colorless oil.
Enantiomers were separated by GC using a Chirasil Dex-CB
chiral stationary phase: 1H NMR (CDCl3) δ 0.75 (d, J ) 7.2
Hz, 3H), 0.87 (d, J ) 7.2 Hz, 3H), 1.51 (s, 6H), 1.87 (d septet,
J ) 2.4, 6.8 Hz, 1H), 2.18 (s, 3H), 2.39-2.57 (m, 2H), 2.76 (dt,
J ) 2.4, 6.8 Hz, 1H); 13C NMR (CDCl3) δ 17.6, 23.8, 24.5, 24.8,
27.4, 29.8, 39.8, 45.9, 91.4, 206.6; HRMS m/z 224.1258 (M +
Na+), calcd for C10H19O3NNa+ 224.1258.
C
14H19O3NNa+ 272.1263.
2,6-Dim eth yl-6-n itr o-5-p h en ylh ep ta n -3-on e (3i) was pu-
rified by FC using Et2O/pentane and isolated as a colorless
solid: 1H NMR (CDCl3) δ 0.90 (d, J ) 6.8 Hz, 3H), 0.98 (d, J
) 6.8 Hz, 3H), 1.49 (s, 3H), 1.56 (s, 3H), 2.48 (septet, J ) 6.8
Hz, 1H), 2.71 (dd, J ) 3.2, 17.2 Hz, 1H), 3.14 (dd, J ) 10.4,
17.2 Hz, 1H), 3.94 (dd, J ) 3.2, 10.4 Hz, 1H), 7.16-7.19 (m,
2H), 7.24-7.29 (m, 3H); 13C NMR (CDCl3) δ 17.8, 17.9, 18.5,
22.6, 26.0, 41.0, 48.7, 91.0, 127.7, 128.4, 129.2, 137.9, 211.0;
HRMS m/z 286.1416 (M + Na+), calcd for C15H21O3NNa+
286.1419.
4-(4-Ch lor op h en yl)-5-m eth yl-5-n itr oh exa n -2-on e (3j)
was purified by FC using Et2O/pentane and isolated as a
colorless oil. Enantiomers were separated by GC using an
Chiraldex G-TA chiral stationary phase. A single recrystal-
ization in EtOH increased the enantioselectivity to 94% ee:
[RrtD] ) -38.0° (c ) 1.0 g/100 mL, EtOH, 94% ee). For details
on the X-ray analysis, see the Supporting Information. 1H
NMR (CDCl3) δ 1.47 (s, 3H), 1.53 (s, 3H), 2.04 (s, 3H), 2.73
(dd, J ) 3.2, 17.2 Hz, 1H), 3.03 (dd, J ) 10.8, 17.2 Hz, 1H),
3.89 (dd, J ) 3.2, 10.8 Hz, 1H), 7.12 (d, J ) 8.4 Hz, 2 H), 7.28
(d, J ) 8.4 Hz, 2 H); 13C NMR (CDCl3) δ 22.5, 25.4, 30.3, 43.8,
48.1, 90.7, 128.7, 130.3, 133.7, 136.1, 204.8; HRMS m/z
292.0719 (M + Na+), calcd for C13H16O3NClNa+ 292.0716.
5-Meth yl-5-n itr o-4-(4-n itr oph en yl)h exan -2-on e (3k) was
purified by FC using Et2O/pentane and isolated as a colorless
oil. Enantiomers were separated by HPLC using a Chiralpak
AD chiral stationary phase in hexane/2-propanol 90/10. A
2-(1-Meth yl-1-n itr oeth yl)-4-oxop en ta n oic a cid m eth yl
ester (3s) was purified by FC using Et2O/pentane and isolated
8336 J . Org. Chem., Vol. 67, No. 24, 2002